Cannabinoids are capable of modulating mood, arousal, cognition and behavior, in part via their effects on the noradrenergic nucleus locus coeruleus (LC). Dysregulation of LC signaling and norepinephrine (NE) efflux in the medial prefrontal cortex (mPFC) can lead to the development of psychiatric disorders, and CB1r deletion results in alterations of α2-and β1-adrenoceptors in the mPFC, suggestive of increased LC activity. To determine how CB1r deletion alters LC signaling, whole-cell patchclamp electrophysiology was conducted in LC-NE neurons of male and female wild type (WT) and CB1r-knock out (KO) mice. CB1r deletion caused a significant increase in LC-NE excitability and input resistance in male but not female mice when compared to WT. CB1r deletion also caused adaptations in several indices of noradrenergic function. CB1r/CB2r-KO male mice had a significant increase in cortical NE levels and tyrosine hydroxylase and CRF levels in the LC compared to WT males.
| INTRODUCTION
The brainstem nucleus locus coeruleus (LC) plays an important role in regulating mood, arousal and emotional states (Aston-Jones & Cohen, 2005; Valentino & Van Bockstaele, 2008) , and is the sole provider of norepinephrine (NE) to the medial prefrontal cortex (mPFC) (Sara, 2009) . Dysregulation of the LC-NE system resulting in subsequent alterations in mPFC NE levels has been shown to precipitate the development of psychiatric disorders (Mueller & Cahill, 2010; Mueller, Porter, & Quirk, 2008) . One of the most widely used recreational drugs in the world, cannabis, often causes feelings of relaxation and euphoria (Di Marzo, Bifulco, & De Petrocellis, 2004; Green, Kavanagh, & Young, 2003; Velez, Johnson, & Cohen, 1989) ; however, chronic usage can be anxiogenic and produces dysphoria (Reilly, Didcott, Swift, & Hall, 1998) . Via activation of cannabinoid type 1 receptors (CB1r), cannabinoids are known to affect attention and anxiety (Hill & Gorzalka, 2009; Pattij, Wiskerke, & Schoffelmeer, 2008; Witkin, Tzavara, & Nomikos, 2005) , in part via actions on noradrenergic circuitry (Carvalho, Mackie, & Van Bockstaele, 2010; Carvalho & Van Bockstaele, 2012; Wyrofsky, Reyes, & Van Bockstaele, 2017) . There are, however, some discrepancies within the cannabinoid field. While some studies find anxiolytic effects and therapeutic promise in cannabinoid treatments, others show that CB1r agonists can have a negative impact and promote anxiogenesis, and the exact dosage and experimental conditions can have a profound effect on whether targeting the endocannabinoid system could be beneficial (Di Marzo, 2008; Wyrofsky, McGonigle, & Van Bockstaele, 2015) . Further investigation of how the eCB system targets neurotransmitter systems, like norepinephrine, can provide further insight into the differential effects of cannabinoid agonism.
Immunofluorescence and immunoelectron microscopy studies have provided direct anatomical evidence for CB1r co-localization to noradrenergic terminals in the mPFC and localization to TH-containing neurons in the LC (Carvalho et al., 2010; Wyrofsky et al., 2017) . Several studies have also shown that CB1r activation increases NE release. CB1r agonists WIN 55,212-2, tetrahydrocannabinol (THC), and CP 55,940 dose-dependently increase the spontaneous firing rate of LC neurons (Mendiguren & Pineda, 2006; Muntoni et al., 2006) . Both systemic and local administration of CB1r agonist WIN 55,212-2 increases c-Fos expression in LC-NE neurons and NE efflux in the rat mPFC (Oropeza, Page, & Van Bockstaele, 2005; Page, Oropeza, & Van Bockstaele, 2008) , as does inhibition of eCB catabolism with a fatty acid amide hydrolase (FAAH) inhibitor (Gobbi et al., 2005) . Additionally, administration of the CB1r antagonist SR141716A causes a decrease in LC activity, suggesting that during basal conditions (Muntoni et al., 2006) , the LC is under tonic eCB regulation (Carvalho & Van Bockstaele, 2012; Wyrofsky et al., 2015) . Conversely, systemic administration of a CB1r antagonist rimonabant causes an increase in mPFC and hypothalamic NE levels (Tzavara, Perry, Rodriguez, Bymaster, & Nomikos, 2001; Tzavara et al., 2003) , and low levels of THC can reduce NE release from synaptosomes (Poddar & Dewey, 1980) . These anatomical and functional studies provide evidence that the eCB system can modulate the LC-NE system.
The eCB system is considered an "anti-stress" neuromediator (Cota, 2008; Viveros, Marco, Llorente, & LopezGallardo, 2007) , playing a role in the hypothalamic pituitary adrenal (HPA) axis negative feedback loop as well as initiating the stress response in the amygdala (Hill & McEwen, 2009; Hill, McLaughlin, et al., 2010; Hill, Patel, et al., 2010) . The LC-NE system is involved in the cognitive limb of the stress response, and is activated in parallel with the HPA axis via corticotropin releasing factor (CRF), the pro-stress neuropeptide (Valentino & Van Bockstaele, 2008) . Following a stressor, CRF is released from limbic and autonomic afferent sources such as the paraventricular nucleus of the hypothalamus, central nucleus of the amygdala and bed nucleus of the stria terminalis (Valentino & Van Bockstaele, 2008; Van Bockstaele, Bajic, Proudfit, & Valentino, 2001; Van Bockstaele, Chan, & Pickel, 1996; Van Bockstaele, Peoples, & Valentino, 1999) , and can lead to increases in LC-NE firing and dysregulation of NE release in target regions, including the mPFC (Curtis, Lechner, Pavcovich, & Valentino, 1996) . We have recently shown that CB1r are positioned both pre-and post-synaptically with respect to CRF-containing afferents within the LC, providing a neural substrate for eCB modulation of CRF in this noradrenergic nucleus (Wyrofsky et al., 2017) .
Research examining male CB1r-knockout (KO) mice show that CB1r deletion increases anxiety and depressivelike behaviors in CB1r KO mice compared to wild type (WT) controls (Aso et al., 2008; Parolaro, Realini, Vigano, Guidali, & Rubino, 2010; Steiner et al., 2008; Wyrofsky et al., 2015) . Additionally, CB1r-KO mice have increased plasma levels of adrenocorticotropin and corticosterone (Uriguen, Perez-Rial, Ledent, Palomo, & Manzanares, 2004) , and increased CRF mRNA expression in the hypothalamus, suggesting heightened HPA activity (Cota, 2008) . We have also demonstrated that CB1r-KO mice have reduced basal mPFC neuronal excitability due to desensitization of the normally excitatory mPFC α2-adrenoceptors (ARs) . These KO studies suggest that CB1r-KO mice have increased LC-NE release, which desensitized mPFC α2-ARs, resulting in decreased mPFC output .
In the present study, we used two strains of cannabinoid receptor KO mice to define electrophysiological properties of LC-NE neurons as well as effects on CRF-mediated responses, and cellular adaptions that occur in absence of the cannabinoid receptors: CB1r-KO mice for in vitro slice electrophysiology studies and dual CB1r/CB2r-KO mice for western blot and ELISA experiments. First, whole-cell patch clamp electrophysiological recordings were conducted in WT and CB1r-KO mice to measure basal properties of LC-NE neurons and their excitability. Next, we used western blot analysis to measure expression levels of the catecholamine synthesizing enzyme tyrosine hydroxylase (TH) in the LC and assessed cortical NE levels via ELISA in CB1r/CB2r-KO mice. We also investigated expression levels of CRF, α2-AR, NET, and CB1r in the coeruleo-cortical pathway. Finally, the effect of CRF administration on LC-NE activity in CB1r-KO mice was assessed using whole-cell patch-clamp recordings. Considering previous reports showing female rodents are more sensitive to the reinforcing effects of cannabinoids and are more likely to self-administer WIN 55,212-2 than males (Barna, Zelena, Arszovszki, & Ledent, 2004; Fattore et al., 2007; Roberts, Stuhr, Hutz, Raff, & Hillard, 2014 ) and sex differences in CRF signaling within the LC, with female rodents having increased sensitivity to CRF following a stressor compared to males (Bangasser et al., 2010; Valentino, Bangasser, & Van Bockstaele, 2013) , we included both male and female mice in the study. These experiments help address the current gap in our understanding of how CB1r-KO differentially affects the LC-NE and stress systems across sexes.
| METHODS

| Animals
For electrophysiology studies, male and female wild-type (WT) and CB1r KO mice (9-12 weeks old) were housed four per cage in a controlled environment (12-hour light schedule, temperature at 20°C). Electrophysiology data for input resistance and excitability were obtained from N = 5 LC cells from five WT male mice, N = 4 cells from four WT female mice, N = 6 cells from five KO male mice, and N = 7 cells from four KO female mice. Electrophysiology data for membrane characteristics were obtained from N = 4 cells from four WT male mice, N = 4 cells from four WT female mice, N = 5 cells from KO male mice and N = 4 cells from KO female mice. For western blot and ELISA analyses, male and female WT and CB1r/CB2r dual KO mice (9-18 weeks old) were used. For LC western blot analysis of CRF, α2-AR and NET, data represent N = 3 WT male mice, N = 6 KO male mice, N = 3 WT female mice and N = 6 KO female mice. For LC western blot analysis of CB1r, data represent N = 7 WT male mice and N = 5 WT female mice. For mPFC western blot and ELISA analyses, data represent N = 3 WT male mice, N = 5 KO male mice, N = 3 WT female mice and N = 4 KO female mice.
Both CB1r and CB1r/CB2r KO mice were originally generated on a C57Bl/6 background by Zimmer et al. (Zimmer, Zimmer, Hohmann, Herkenham, & Bonner, 1999) at the National Institutes of Health. Heterozygous breeding pairs were generously donated by Dr. Carl Lupica at the National Institutes of Health and were bred and genotyped at Temple University to obtain CB1r and CB1r/CB2r KO mice and WT littermates. All WT mice used in comparison with CB1r or CB1r/CB2r KO mice were littermates and shared a common genetic background. Food and water were provided ad libitum.
The care and use of animals were approved by the Institutional Animal Care and Use Committee of both Drexel University and Temple University, and were conducted in accordance with the National Institutes of Health's Guide for the Care and Use of Laboratory Animals (1996) , the Health Research Extension Act (1985) and the PHS Policy on Humane Care and Use of Laboratory Animals (1986). All efforts were made to utilize only the minimum number of animals necessary to produce reliable scientific data, and experiments were designed to minimize any animal distress.
| Drug preparation and administration
Ovine CRF, generously provided by Dr. Jean Rivier (Clayton Foundation Laboratories for Peptide Biology, The Salk Institute, La Jolla, CA, USA), was dissolved in water to make a 1 mg/ml solution and separated into 10 μl aliquots, which were concentrated using a Savant SpeedVac concentrator. Aliquots were stored at −80°C until the day of the experiment, when they were then reconstituted in artificial cerebrospinal fluid (aCSF) and added to the perfusion bath at a final concentration of 300 nM CRF. 300 nM CRF was established as the optimal concentration based on a concentrationresponse curve (100-400 nM) tested in brain slices from male WT mice (data not shown). Additionally, this dose matches with previous sources confirming that 300 nM CRF produces maximal increases in LC-NE excitability (Jedema & Grace, 2004) .
| Electrophysiology
All electrophysiology procedures were conducted as described previously (Cathel et al., 2014; Reyes et al., 2012) . Male and female CB1r KO and WT mice were rapidly decapitated and brains rapidly extracted and placed in ice-cold aCSF, in which sucrose (248 mM) was substituted for NaCl.
The brains were trimmed down to isolate the brainstem, and 250 μm horizontal slices containing the LC were cut on a Vibratome 3000 Plus (Vibratome, St. Louis, MO, USA). Slices were then incubated for 1 hr in aCSF at 35°C, and bubbled with 95% O 2 /5% CO 2 . Slices were then maintained at aCSF at room temperature and bubbled with 95% O 2 /5% CO 2 . The aCSF was composed of the following: 124 mM NaCl, 2.5 mM KCl, 2 mM NaH 2 PO 4 , 2.5 mM CaCl 2 , 2 mM MgSO 4 , 10 mM dextrose and 26 mM NaHCO 3 .
Slices were transferred to a recording chamber (Warner Instruments, Hamden, CT, USA) and continuously perfused with aCSF at a rate of 1.5-2.0 ml/min at a temperature of 34°C, maintained by an inline solution heater (TC-324; Warner Instruments, Hamden, CT, USA). Data were obtained from one to two neurons per mouse; however, only one neuron was recorded per brain slice. Neurons in the LC were visualized using a Nikon E600 upright microscope fitted with a 40x water immersion objective, differential interference contrast and infrared filter (Optical Apparatus, Ardmore, PA, USA). The microscope was connected to a CCD camera and computer monitor. LC-NE cells were tentatively identified by their morphology and electrophysiological characteristics (Williams, North, Shefner, Nishi, & Egan, 1984) , using the fourth ventricle as a marker for the location of the LC nucleus. Whole-cell recording pipettes were made with borosilicate glass capillary tubing (1.2 mm outer diameter, 0.69 mm inner diameter; Warner Instruments) on a P-97 micropipette puller (Sutter Instruments, Novato, CA, USA). Electrodes were pulled to a resistance of 4-8 MΩ when filled with an intracellular solution containing 120 mM K-gluconate, 10 mM KCl, 1 mM MgCl 2 , 10 mM EGTA, 10 mM HEPES, 2 mM MgATP, 0.5 mM Na 2 GTP, 10 mM Na phosphocreatinine and 0.1% biocytin, pH 7.3. Cells were approached with the electrode until a GΩ seal was established, and the cell membrane ruptured to obtain a whole-cell recording using HEKA patch-clamp EPC-10 amplifier (HEKA Elecktronik, Pfalz, Germany) under current clamp conditions (I = 0 pA). The series resistance was monitored throughout the experiment, and if it appeared unstable or exceeded four times the electrode resistance, the cell was discarded. Signals were stored on-line using Pulse software, filtered at 1 kHz and digitized at 10 kHz. The liquid junction potential was approximately 9 mV between the pipette solution and the aCSF, and was not subtracted from the data obtained.
At baseline, membrane potential was recorded and input resistance calculated by averaging the voltage change that occurred during a 300 pA current pulse and using the current/ voltage relationship. Neuronal excitability was assessed in each cell by injecting a series of current pulses (0-180 pA, 30 pA increments), and the number of action potential per pulse was determined. Additionally, membrane characteristics were recorded, including action potential (AP) amplitude, AP duration, AP threshold, afterhyperpolarization potential (AHP) duration, and AHP amplitude. After baseline recordings were performed, 300 nM CRF was bath applied, and membrane potential, input resistance, neuronal excitability and membrane characteristics were re-assessed 6 min after drug application.
Following electrophysiological experiments, dual fluorescence immunohistochemistry techniques were used to confirm that recordings were performed in LC-NE cells. Slices that were used for recordings were post-fixed in 4% formaldehyde solution on 0.1 M phosphate buffer (PB; pH 7.4) for 72 hr. Biocytin-filled (recorded) neurons were visualized using an Alexa Fluor 488-conjugated streptavidin antibody (1:500, ThermoFisher Scientific, Waltham, MA, USA). Tyrosine hydroxylase (TH) was visualized using a primary TH antibody raised in mouse (1:1,000, 48 hr incubation, Immunostar, Hudson, WI, USA) followed by Alexa Fluor 647-conjugated mouse secondary antibody (1:400, Jackson ImmunoResearch, West Grove, PA, USA). Images were examined using an Olympus IX81 inverted microscope (Olympus, Hatagaya, Shibuya-Ku, Tokyo, Japan) equipped with lasers (Helium Neon laser and Argon laser; models GLG 7000; GLS 5414A and GLG 3135, Showa Optronics Co., Tokyo, Japan) with the excitation wavelength of 488, 543 and 635. Data from recorded cells that were not costained with TH were excluded.
| Data analysis for electrophysiology
Electrophysiological recordings were analyzed using Clampfit 9.2 (Axon Instruments, Foster City, CA, USA). The effect of genotype on input resistance and membrane characteristics across males and females was tested using two-way ANOVA (sex*genotype) followed by post-hoc Tukey's multiple comparison adjustments. The effect of CRF on input resistance and membrane characteristics across genotypes of males and females was tested using two-way ANOVA (sex*genotype) followed by post-hoc Tukey's multiple comparison adjustments. These statistics were performed using GraphPad Prism 7.03 (GraphPad Software, San Diego, CA, USA). The effect of sex and genotype on neuronal excitability was tested using a three-way repeated measure ANOVA/ mixed-effects regression model (with sex, genotype and injected current as covariates, along with a random effect for repeated measures from injected current), while the effect of CRF on neuronal excitability was tested by using a second mixed-effects regression model (with sex, genotype, injected current and drug treatment as covariates, along with a random effect for repeated measures from injected current and drug treatment), both followed by post-hoc Tukey's multiple comparison adjustments when appropriate. Statistical analyses for neuronal excitability were performed using SAS version 9.4 (SAS Institute Inc., Cary, NC, USA). Results are presented as mean ± SEM, based on the number of cells
per group. p-values <0.05 were considered statistically significant.
| Protein extraction
Brain tissue from male and female WT and CB1r/CB2r KO mice was rapidly removed from each animal on ice. Using a trephine, the LC and mPFC brain regions were microdissected from each animal. Tissue punches were homogenized with a pestle, sonicated and extracted in radioimmunoprecipitation assay lysis buffer with a protease inhibitor cocktail (Santa Cruz Biotechnology, Santa Cruz, CA, USA) on ice for 20 min. Lysates were cleared by centrifugation at ~20,000 g for 12 min at 4°C, and supernatants were extracted. Protein concentrations were quantified using the bicinchoninic acid protein assay reagent (Pierce, Rockford, IL, USA).
| Western blot analysis
Protein extracts were diluted with an equal volume of Novex 2© tris-glycine sodium dodecyl sulfate sample buffer (Invitrogen, Carlsbad, CA, USA) containing dithiothreitol (Sigma-Aldrich Inc., St. Louis, MO, USA). Cell lysates containing equal amounts of protein (30 μg per condition) were separated on 10% tris-glysine polyacrylamide gels and then electrophoretically transferred to Immobilon-P polyvinylidene fluoride membranes (Millipore, Bedford, MA, USA). Membranes were blocked with Odyssey buffer (1 hr, diluted in 0.01 M PBS 1:1) and incubated in the various combinations of the following primary antibodies overnight at room temperature (Table 1) : mouse anti-tyrosine hydroxylase (TH; 1:1,000, Immunostar Inc.), rabbit anti-α2-adrenoceptor (α2-AR; 1:500; Millipore Sigma, Billerica, MA, USA), guinea-pig anti-CRF (1:2,000, Peninsula Laboratories, San Carlos, CA, USA), mouse anti-norepinephrine transporter (NET; 1:1,000, Millipore Sigma), guinea-pig anti-CB1r (1:500; gift from Dr. Mackie). Mouse anti-glyceraldehyde 3-phosphate dehydrogenase (GAPDH; 1:2,000, ProteinTech Group, Inc., Rosemont, IL, USA) was used as a loading control, to account for potential variability in amount of sample loaded. Membranes were then rinsed and incubated with infrared fluorescent secondary antibodies (Licor, Lincoln, NE, USA) for 1 hr: donkey anti-rabbit IRDye 800CW (1:15,000), donkey anti-guinea-pig IRDye800 CW (1:15,000), goat antimouse IRDye680LT (1:20,000). Membranes were scanned using the Odyssey Infrared Imaging System (Licor), and protein quantification was determined using Odyssey Infrared Imaging software. Protein quantification was normalized to the loading control, and all data are presented as a ratio of sample protein level to GAPDH level, to allow for comparison between groups.
Additionally, Chameleon Duo Pre-stained Protein Ladder (Licor) was used to determine the molecular Ross, Reyes, Thomas, and Van Bockstaele (2018) weights of protein bands observed: GAPDH -~37 kDa, CRF -~25 kDa, α2-AR -~45 kDa, TH -~60 kDa, NET -~80 kDa, CB1r -~53 kDa. Only proteins that did not fall around the same molecular weight were probed for at the same time. After imaging, membranes were stripped with NewBlot PVDF 5x Stripping Buffer (Licor, Lincoln, NE, USA) mixed with four parts DiH 2 O for 20 min at room temperature. Blots were then rinsed and imaged to ensure removal of antibodies. Then, the blot could be incubated again with other primary antibodies to detect additional proteins.
| ELISA
Sandwich ELISA was conducted in accordance with the instructions provided in the High Sensitivity NE Kit (Eagle, Nashua, NH, USA). Tissue lysates containing equal amounts of protein were dispensed into an extraction plate and incubated for 60 min in 100 μl extraction buffer at room temperature on an orbital shaker. The solution was then discarded and the extraction plates were washed before 200 μl acylation buffer was dispensed into each well of the extraction plate and left rotating at room temperature for 20 min. Liquid was then decanted and washed three times prior to the dispense of 125 μl 0.025 M hydrochloric acid into each well for an additional 20 min for elution. Next, 100 μl eluent was transferred to the enzyme plate with 20 μl of freshly prepared enzyme mix (2 ml Catechol-O-methyltransferase with 0.3 ml S-adenosyl-L-methionine in 0.7 ml enzyme buffer) into all wells of the enzyme plate and left at room temperature for 90 min. Finally, 100 μl of the supernatant of each well was transferred to the NE ELISA with 20 μl of rabbit NE-antiserum and left overnight at 4°C. The following day, all wells were decanted and washed three times before incubation with 100 μl anti-rabbit IgG-POD-conjugate for 60 min at room temperature on an orbital shaker. The wells were subsequently washed four times and incubated with 100 μl of TMB solution for 40 min before 100 μl of stop solution was dispensed into the wells and the plate was read at 450 nm within 15 min. A standard curve was run for each replicate and was used to estimate the concentration of NE in each sample.
| Data analysis for western blot and ELISA
Differences in CRF, α2-AR, NET, TH and NE levels were tested using two-way ANOVA/mixed-effects regression model (sex*genotype) followed by post-hoc Tukey's multiple comparison adjustments. Differences in CB1r expression across sexes were tested using a two-sample t test. Statistics for the western blot and ELISA experiments were performed using GraphPad Prism 7.03 (GraphPad Software, San Diego, CA, USA). Results are presented as mean ± SEM. p-values <0.05 were considered statistically significant.
| RESULTS
| Heightened LC-NE activity in male
CB1r-KO mice
As previously stated, exogenous cannabinoids are known to increase LC-NE activity (Muntoni et al., 2006; Patel & Hillard, 2003) . Conversely, others studies have shown that the LC is under tonic eCB regulation and male CB1r-KO mice have decreased α2-and β1-adrenoceptor levels in the mPFC, suggestive of compensatory responses to heightened LC-NE activity . In order to elucidate the effect of CB1r-KO on LC-NE signaling across sexes, whole-cell patch-clamp recordings from LC-NE neurons in 250 μm thick horizontal brain slices from CB1r-KO mice and their WT C57/Bl6 mice littermates were analyzed ( Figure 1 ). There was a significant effect of sex on input resistance (F 1,17 = 4.485, p = 0.049) and genotype on input resistance (F 1,17 = 13.24, p = 0.002), but no significant effect of interaction between sex and genotype on input resistance (F 1,17 = 2.972, p = 0.10). Tukey's post-hoc analysis revealed that male CB1r-KO mice showed a significant increase in input resistance (376 ± 31 MΩ) when compared to male WT mice (224 ± 13 MΩ; p = 0.006), female WT mice (213 ± 39 MΩ; p = 0.005) and female KO mice (267 ± 25 MΩ; p = 0.041), while there was no significant change in input resistance between female WT and KO mice (p = 0.57) (Figure 1b Figure 1a ). Slices containing patched cells were processed for immunohistochemistry, to confirm that the data were collected from NE producing cells within the LC. Only cells that were labeled with both TH, a marker for NE production in the LC, and biocytin were included in the analyses (Figure 2 ). These data provide evidence that genetic deletion of CB1r increases LC-NE neuron excitability in males, increasing the ability of these male CB1r-KO LC-NE cells to respond to excitatory synaptic inputs. Another way to assess alterations in LC-NE activity is to look at changes in NE production (Figure 3 ). Tyrosine hydroxylase (TH) is involved in the rate-limiting step in NE synthesis, and is used as a marker for NE production within the LC. There was a significant effect of genotype on TH expression levels (F 1,14 = 11.00, p = 0.005), but no significant effect of sex on TH expression (F 1,14 = 4.287, p = 0.057) or interaction sex*genotype on TH expression (F 1,14 = 3.753, p = 0.073). Tukey's post-hoc analysis revealed that WT male mice have significantly lower normalized levels of TH (0.313 ± 0.049) compared to CB1r/ CB2r-KO males (0.751 ± 0.064; p = 0.011) and KO females (0.672 ± 0.061; p = 0.009), while no significant increase is observed between WT (0.639 ± 0.141) and KO females (0.672 ± 0.061; p = 0.77) (Figure 3a) . By using an ELISA, it is possible to more precisely determine changes in NE levels in the mPFC, representing a concrete endpoint for the effect of cannabinoid receptor deletion on LC-NE activity. Twoway ANOVA indicated a significant effect of genotype on NE levels (F 1,11 = 9.719, p = 0.01), but no significant effect of sex on NE levels (F 1,11 = 4.825, p = 0.050) or interaction sex*genotype on NE levels (F 1,11 = 3.151, p = 0.10). Male CB1r/CB2r-KO mice have significantly increased levels of NE in the mPFC (0.151 ± 0.032 pg/ml; p = 0.021) compared to all other groups (Figure 3b ): WT males (0.049 ± 0.008 pg/ ml), WT females (0.039 ± 0.003 pg/ml; p = 0.012) and KO females (0.071 ± 0.011 pg/ml; p = 0.041). There was no significant difference in NE levels between WT and KO females (p = 0.79). The western blot and ELISA data confirm that deletion of the CB1r causes a significant increase in NE indices in male but not female mice.
| Sex differences in cellular adaptations following cannabinoid receptor deletion
In order to better understand what might be causing the increase in LC-NE activity in male CB1r-KO mice but not females, western blot analyses were performed to determine what other changes in protein levels might be occurring (Figure 4) . Within the LC, the α2-AR functions to auto-inhibit LC-NE neurons. When examining changes in normalized α2-AR protein levels following CB1r/CB2r deletion (Figure 4a ), a two-way ANOVA determined a significant effect of genotype on α2-AR expression (F 1,14 = 10.62, p = 0.006), but no significant effect of sex (F 1,14 = 3.004, p = 0.11) or interaction of sex*genotype (F 1,14 = 2.927, p = 0.11) on α2-AR expression. Tukey's post-hoc analysis showed no significant change between WT males (0.560 ± 0.027) and KO males (0.721 ± 0.054; p = 0.70); however, KO females (0.720 ± 0.059) showed a significant increase compared to WT females (0.386 ± 0.098; p = 0.016). CB1r-KO mice have heightened HPA-activity and the LC is involved in the cognitive limb of the stress response; therefore, changes in CRF levels within the LC were also determined (Figure 4b ). Twoway ANOVA revealed a significant effect of genotype on CRF expression (F 1,14 = 8.57, p = 0.011), but no significant effect of sex on CRF expression (F 1,14 = 0.3233, p = 0.58) or interaction sex*genotype on CRF expression (F 1,14 = 1.586, 
F I G U R E 4 Western blot analysis of α2-adrenoreceptor (α2-AR), corticotropin-releasing factor (CRF), and norepinephrine transporter (NET)
expression in the LC and mPFC in male and female WT and CB1r/CB2r-KO mice. Bands shown are representative of one sample obtained from one animal per group. LC blots were stripped and reincubated, and multiple proteins were probed on the same blots. (a) Western blot analysis for α2-AR expression in protein extracts from the LC of male and female WT and CB1r/CB2r-KO mice. CB1r/CB2r deletion causes a significant increase in α2-AR expression compared to WT mice in females (p = 0.016), but no change in males (p = 0.70). N = 3 WT males, N = 6 KO males, N = 3 WT females and N = 6 KO females. (b) Western blot analysis for CRF expression in protein extracts from the LC of male and female WT and CB1r/CB2r-KO mice. There is a significant increase in CRF levels in the LC of male CB1r/CB2r-KO mice compared to male WT mice (p = 0.045), while no change occurs in female mice (p = 0. The increase in CRF expression in male KO mice compared to WT and α2-AR expression in female KO mice compared to WT might provide some insight into why CB1r-deletion causes an increase in LC-NE excitability in males but not females. Additionally, basal differences in CB1r expression across sexes could account for the observed electrophysiological differences following CB1r deletion. To investigate this, western blot analysis on male and female WT mice was performed (Figure 4e ). Two-sample t test analysis revealed a significant difference in CB1r expression between males (0.379 ± 0.056) and females (0.162 ± 0.068; t 10 = 2.469, p = 0.033). Less CB1r expression in females could be contributing to the increased basal LC-NE excitability in WT females compared to males, as well as the lack of increase in LC-NE excitability in CB1r-KO females compared to WT females.
| Loss of CRF-induced increases in
LC-NE excitability in CB1r-KO mice
We determined how CRF affects LC-NE excitability under conditions of CB1r deletion. After baseline measurements were recorded from male and female WT neurons, CRF (300 nM) was bath applied and the effect of drug treatment was then recorded. This dose of CRF did not cause a significant increase in the input resistance of male (Figure 5b ) or female (Figure 5b ') WT and CB1r-KO mice when compared to baseline: male WT CRF (274 ± 29 MΩ), male KO CRF (417 ± 52 MΩ), female WT CRF (259 ± 43 MΩ) and female KO CRF (282 ± 48 MΩ). Data for neuronal excitability were analyzed using a four-way repeated measure ANOVA/mixed-effects regression model (sex effect by genotype*current pulse, genotype effect by sex*current pulse, genotype effect by drug treatment*current pulse, drug effect by genotype*current pulse) and the following effects were found significant: drug treatment (F 1,20 = 6.92, p = 0.016), current pulse (F 6,108 = 159.27, p < 0.0001), interaction sex*genotype (F 1,18 = 10.55, p = 0.005), interaction genotype*current pulse (F 6,108 = 4.85, p = 0.0002), interaction sex*genotype*current pulse (F 6,108 = 4.80, p = 0.0002) and interaction genotype*drug treatment (F 1,20 = 5.48, p = 0.03), indicating all four factors were important predictors of neuronal excitability. CRF (300 nM) treatment caused a significant increase in LC-NE cell excitability in both male WT (Figure 5c ) and female WT (Figure 5c ') mice, as expected. Tukey's post-hoc analysis showed a significant drug treatment effect across WT male and female mice (p = 0.0002 for 30 pA current pulses and p < 0.0001 for 60, 90, 120, 150, and 180 pA current pulses). Interestingly, CRF did not cause a significant increase in LC-NE cell excitability in male ( Figure 5d ) and female (Figure 5d ') CB1r-KO mice, as the post-hoc analysis showed no significant effect of drug treatment across KO male and female mice (p ≥ 0.63). Representative traces from each group showing the number of spikes caused by 120pA current pulse are provided in Figure 5 : male WT baseline -11 spikes, male WT CRF -16 spikes, male KO baseline -25, male KO CRF -28 (Figure 5a ), female WT baseline -25 baseline, female WT CRF -33, female KO baseline -28, female KO CRF -30 (Figure 5a ). These electrophysiological results suggest that while 300 nM CRF causes a significant increase in LC-NE cell excitability in WT male and female mice, it is not capable of producing the same effect in CB1r-KO mice.
When examining single action potentials, CRF administration, sex and genotype did not affect many of the analyzed characteristics (Table 2) . Resting membrane potential remained constant among all groups, as did action potential threshold, duration, amplitude, and afterhyperpolarization amplitude. CRF administration did cause a significant decrease in afterhyperpolarization duration in WT males (p = 0.004), KO males (p = 0.047) and WT females (p = 0.002), but not in KO females (p = 0.069) (Figure 6 ). CB1r deletion also caused a significant reduction in afterhyperpolarization duration in males (p = 0.013), but not in females (p = 0.29). 
| DISCUSSION
The present study highlights interesting sex differences in LC neurons following cannabinoid receptor deletion. Electrophysiological studies conducted using an in vitro slice preparation show that CB1r deletion results in a significant increase in LC-NE excitability in male mice, but not in females. Additionally, male CB1r-KO mice have a significant increase in TH expression in the LC and NE levels in the mPFC compared to WT males, which is not observed in females. Via western blot analysis, changes in protein expression across genotype and sex were observed. Male CB1r/CB2r-KO mice exhibited an increase in CRF expression and a decrease in NET expression in the LC compared to male WT mice, and female CB1/CB2r-KO mice had an increase in α2-AR levels in the LC compared to female WT mice. Basal differences in CB1r expression were also observed, with male WT mice having higher CB1r levels than female WT mice. Finally, CB1r deletion affected CRF-induced increases in LC-NE activity. Bath application of CRF caused an increase in LC-NE excitability in male and female WT mice; however, the effect of CRF was lost in CB1r-KO mice. When examining individual membrane characteristics, LC-NE cells from male CB1r-KO mice showed a decrease in afterhyperpolarization duration. Additionally, CRF treatment caused a further decrease in afterhyperpolarization duration in LC-NE neurons from WT males and CB1r-KO males, and also a decrease in WT females. These data further highlight the importance of the endocannabinoid system in maintaining normal brain adrenergic function, especially in male mice, where CB1r deletion had the most profound effect.
| Methodological considerations
While electrophysiology experiments were carried out in CB1r-KO mice, western blot and ELISA experiments were carried out in CB1r/CB2r-KO mice due to tissue availability. Many immunohistochemical studies have identified CB1r as an abundant protein in the LC, both directly on the noradrenergic neurons as well as on presynaptic afferents synapsing onto LC-NE dendrites and cell bodies (Scavone, Mackie, & Van Bockstaele, 2010; Wyrofsky et al., 2017) . While CB2r is traditionally thought to play a role in the periphery and immune responses (Castillo, Younts, Chavez, & Hashimotodani, 2012) , growing accumulating evidence suggests that it does in fact play a role in neuronal signaling in some select brain regions (Gong et al., 2006; Van Sickle et al., 2005) . However, direct evidence of CB2r on LC-NE neurons has not been shown. Additionally, mixed CB1r/CB2r agonists such as THC, WIN 55,212-2 and CP 55,940 all dose-dependently increase LC-NE firing, and their effects are completely blocked by CB1r-selective antagonist SR141716A (Mendiguren & Pineda, 2006; Muntoni et al., 2006) . These studies suggest that there is a significantly greater influence of CB1r than CB2r on LC-NE neurons, providing indirect evidence for a minimal role of CB2r signaling in the LC. Therefore, the effects of CB2r deletion in the LC should be less substantial than that of CB1r deletion, and the differences between CB1r-KO mice and CB1r/CB2r-KO mice should be minimal. However, the caveat exists that findings reported here are due to deletion of both receptor phenotypes.
Several studies have reported fluctuations in CB1r mRNA expression and eCB levels across the estrus cycle in several brain regions, including the anterior pituitary (Gonzales et al., 2000) and hypothalamus (Rodriguez de Fonseca, Cebeira, Martin, & Fernandez-Ruiz, 1994) ; however, the effect of ovarian hormones on CB1r and eCB levels in the LC has not been identified. While estrogen might alter the endocannabinoid system, no effect of the estrus cycle was observed in preliminary studies examining the anti-depressant like behavioral effects of CB1r antagonism (Steiner et al., 2008) . Additionally, a study specifically examining the LC region controlled for the estrus cycle and found no notable effect of phase on female LC-NE excitability, firing rate or CRFr1 compartmentalization in both WT and CRF-overexpressing mice . Since no direct effect of estrus cycle was has been found on baseline WT LC-NE excitability, and since the effect of circulating sex hormones on the eCB system is less relevant when CB1r are genetically deleted, we did not note the estrus cycle prior to our experiments, though the caveat exists that controlling for the estrus cycle could alter our results.
Some experimental caveats exist with western blot and ELISA analysis, including the accuracy of tissue punches and equal protein quantities across various animals and groups. In order to ensure that regions of interest were sampled accurately, one investigator preformed the micropunches for each animal. Additionally, western blots were probed with GAPDH as an internal standard to ensure equal protein loading for each sample. Results were normalized to GAPDH expression, which was comparable across each animal group examined. Finally, while western blot analysis allows us to examine changes in protein expression levels, subsequent studies examining changes in mRNA levels could be conducted to further elucidate the effects of CB1r deletion on noradrenergic indices in the LC.
| Basal differences in LC-NE excitability across sexes
Whole-cell patch-clamp electrophysiology revealed that female WT mice have increased LC-NE excitability compared to male WT mice. This implies that female WT LC-NE cells have an increased sensitivity to depolarizing stimuli than male WT cells. It is important to note that while WT females have heightened excitability, this does not correlate to a heightened basal firing rate. Previous studies by Bangasser et al. similarly found that female WT mice have increased LC-NE excitability compared to males, but the basal firing rate of these neurons is not significantly different across sexes . In corroboration with Bangasser's findings that male and female LC-NE neurons have similar firing rates, our study shows that there is no significant difference in NE levels in the mPFC across sexes -another endpoint for LC-NE firing. While we observe an increase in LC-NE excitability in male CB1r-KO mice, we did not examine the basal firing rates between male and female WT and CB1r-KO mice. It would be tempting to postulate that CB1r-KO males would also have an increase in LC-NE firing rate compared to the other groups, as they are the only group with increased mPFC NE levels. Subsequent electrophysiology studies could further elucidate this hypothesis.
| CB1r-KO increases LC-NE excitability in males but not females
One of the most interesting and surprising findings from this study is that CB1r deletion affected LC-NE excitability selectively in male subjects. The changes observed in input resistance and afterhyperpolarization (AHP) duration across sex and genotype are consistent with the changes observed in LC-NE excitability. All groups that had heightened LC-NE excitability also showed a decrease in AHP duration: CB1r-KO males and WT females compared to WT males, CRF treated WT males and females compared to baseline. Additionally, CB1r-KO male and CRF treated WT males and females all had an increase in input resistance, suggesting a decrease in ion channel conductance. Neuronal increases in 3′,5′-cyclic adenosine monophosphate (cAMP) cause increased Ca 2+ efflux. Ca 2+ -mediated increases in K + conductance occur in LC-NE cells, leading to more rapid repolarization (Adams, Constanti, Brown, & Clark, 1982; Nestler, Alreja, & Aghajanian, 1999; Osmanovic & Shefner, 1993 ). An increased repolarization rate corresponds with a shorter AHP duration, and suggests a general decrease in overall K + ion conductance (Adams et al., 1982) . Results from the western blot analysis provide further insight into why only certain groups had increased excitability. In males, a potential mechanism underlying increased LC-NE excitability involves differences in CRF expression. Interestingly, only male CB1r/CB2r-KO mice showed an increase in CRF expression in the LC when compared to WT and female subjects. This was surprising initially, since many studies have shown that CB1-KO mice have heightened HPA axis activity and increased vulnerability to chronic stress (Martin, Ledent, Parmentier, Maldonado, & Valverde, 2002; Uriguen et al., 2004) , and female rodents are known to T A B L E 2 Action potential and afterhyperpolarization characteristics of LC-NE neurons before and after 300 nM CRF bath application in wild type (WT) and CB1r-knock out (KO) male and female mice have increased susceptibility to stressors compared to males (Bangasser & Valentino, 2012; Handa & Weiser, 2014) . However, more recent studies examining mice of both sexes report that females do not show HPA axis hyperactivity to the same degree as males following CB1r deletion or antagonism (Atkinson et al., 2010; Roberts et al., 2014) . Thus, since the LC-NE cognitive limb of the stress response is engaged in parallel with the HPA axis (Valentino & Van Bockstaele, 2008; Van Bockstaele, Colago, & Valentino, 1998) , it is tempting to speculate that female CB1r-KO mice might show less of an increase in CRF release in the LC compared to males. CRF binds to its receptor, CRFr1, on LC-NE neurons and increases LC-NE firing rate (Curtis et al., 1996) . Both acute and chronic stress upregulate the cAMP pathway (Nestler & Aghajanian, 1997) , which, through downstream effects, increases neuronal repolarization and decreases LC-NE AHP duration (Adams et al., 1982; Nestler et al., 1999) . Therefore, increased CRF expression represents one mechanism by which CB1r-KO males might have increased LC-NE excitability while female CB1r-KO mice do not (Figure 7b ).
Another potential mechanism underlying the observed sex differences in this study involves alterations in α2-AR expression between female CB1r/CB2r-KO and WT mice. NE released from recurrent collaterals of LC neurons can bind to postsynaptic α2-AR on the LC-NE dendrites resulting in auto-inhibition (Lee, Rosin, & Van Bockstaele, 1998a,b) . In response, an increase in α2-AR would result in a decrease in cAMP and inhibition of LC-NE neurons, which is characterized by an increase in AHP and decrease in input resistance (Korf, Aghajanian, & Roth, 1973) . While CB1r/ CB2r deletion does not affect α2-AR levels in males, it does cause a significant increase in α2-AR expression in females. This could represent a compensatory mechanism in females, where another inhibitory receptor, α2-AR, is upregulated to compensate for the loss of another inhibitory receptor, CB1r (Figure 7b' ). This results in comparable excitability levels across LC-NE neurons, input resistance, and AHP duration in CB1r-KO and WT females.
Lastly, the observed sex difference in basal CB1r expression is likely a key contributor to the electrophysiological variances across sexes. While there are conflicting data surrounding the effects of CB1r antagonists on LC-NE activity, studies performed on male rodents show that they do alter LC-NE firing, suggesting there is tonic eCB activity in males (Carvalho & Van Bockstaele, 2012; Wyrofsky et al., 2015) . One study found that a low dose of a CB1r antagonist resulted in an increase in NE release in the mPFC (Tzavara et al., 2003) . This mimics what was observed in the male CB1r-KO mice, where abolishing CB1r signaling receptor deletion caused an increase in NE release. One final reason why female CB1r-KO mice might not have shown a significant increase in LC-NE excitability and NE efflux could be because they have less CB1r expression, so their deletion would have less profound of an effect on LC cells compared to males. Future studies examining the effect of CB1r antagonists in females would provide additional support for this hypothesis. Additionally, while less CB1r expression could indicate less tonic eCB signaling in the female LC, it is important to note that other eCB proteins play a role as well. Basal differences in FAAH and other eCB metabolic proteins might also exist between males and females, further implicating a difference in tonic eCB regulation of the LC. Subsequent western blot analyses investigating their expression should be performed to determine their contribution to changes in LC-NE excitability across sexes and genotype.
| Loss of CRF-mediated responses in
CB1r-KO mice
Although CRF is known to modulate LC-NE neurons and increase their firing rate (Curtis et al., 1996; Jedema & Grace, 2004; Valentino, Curtis, Page, Pavcovich, & Florin-Lechner, 1997) , and this study confirmed that 300 nM CRF bath application is capable of doing so in LC neurons from WT males and females, this effect was not observed in CB1r-KO mice. This loss of CRF-mediated increases in LC-NE excitability in male CB1r-KO mice could be due to the increased endogenous CRF levels saturating CRFr1, rendering the exogenous application of ovine corticotropin releasing factor (oCRF) ineffective (Figure 7c ). In female CB1r-KO mice, the lack of CRF-induced responses might be attributed to the increased α2-AR expression, causing local auto-inhibition and attenuation of LC-NE activity following oCRF administration (Figure 7c') .
Additionally, chronic stress has been shown to alter CRFr1 trafficking in a sex dependent manner, with males exhibiting increased stress-induced internalization while females exhibit stress-induced recruitment to the plasma membrane (Bangasser et al., 2010; Valentino et al., 2013) . It is possible that increased HPA hyperactivity (Uriguen et al., 2004 ) and a chronic increase in CRF levels in the LC of male CB1r-KO mice could lead to sustained de-sensitization of CRF receptors. Immunoelectron microscopy experiments examining CRF receptor trafficking in LC-NE neurons of male and female CB1r-KO mice could provide further insight into changes in the stress circuitry following CB1r deletion.
| IMPLICATIONS FOR PHARMACOTHERAPIES
Dysregulation of NE is a key component in the development of anxiety and other stress-induced psychiatric disorders (Carvalho & Van Bockstaele, 2012) . Furthermore, reduction in NET expression in the LC has been identified in individuals suffering from major depression and PTSD (Klimek et al., 1997; Pietrzak et al., 2013) . While acute stress does not affect NET levels, chronic and repeated stress exposure can lead to downregulation (Zafar, Pare, & Tejani-Butt, 1997) . Increased turnover and NE depletion, which can occur following a stressor (Korf et al., 1973) , also leads to the downregulation of NET and upregulation of TH, and increased TH levels in the LC have also been correlated with the development of depression (Klimek et al., 1997) . Male CB1r/CB2r-KO mice exhibit a decrease in NET and an increase in TH expression, while no change was observed between female CB1r/CB2r-KO and WT mice. These findings suggest that CB1r deletion or chronic antagonism may be more detrimental to males than females, creating a microenvironment in the LC of male KO mice that mimics conditions of chronic stress.
In addition to cellular adaptations that occur following cannabinoid receptor deletion, the lack of increase in LC-NE excitability in female CB1r-KO mice could be due to less basal eCB signaling in females. If the female LC is under less tonic regulation by eCBs, then removal of CB1r might have less profound of an effect. In the amygdala, basal differences in the eCB system have been observed across sex, with males having greater levels of 2-AG and AEA, while females have increased expression of the enzymes responsible for their degradation (Craft, Marusich, & Wiley, 2013; Krebs-Kraft, Hill, Hillard, & McCarthy, 2010) . A similar phenomenon might exist in the LC, and future western blot and ELISA analyses of 2-AG, AEA and their metabolic and synthesizing enzymes would provide further insight into potential basal sex differences.
We have demonstrated in previous studies that CB1r are localized to CRF-containing afferents from the amygdala, and their presynaptic distribution in the peri-LC suggests that they might be capable of attenuating CRF release via activation by endogenous or exogenous cannabinoids. A working model (Figure 7a ) is that CRF released from amygdalar afferents binds to postsynaptic CRFr1 on LC-NE neurons, causing membrane depolarization and increase in LC-NE excitability. However, the influx of Ca 2+ then stimulates the synthesis and | WYROFSKY et al.
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Schematic depicting the effects of CB1r deletion on LC-NE indices. This schematic is contains a combination of results from electrophysiology studies performed in CB1r-KO mice with western blot and ELISA analysis performed on CB1r/CB2r-KO tissue. (a) Our working model depicting how the endocannabinoid (eCB) system might modulate CRF-mediated responses within the LC.
(1) Stressors cause CRF to be released from excitatory amygdalar afferents into the LC. (2) CRF binds to its postsynaptic CRF type 1 receptor (CRFr1), and subsequent postsynaptic depolarization and Ca 2+ influx leads to increased LC-NE excitability and NE efflux in the mPFC. (3) Increased intracellular Ca 2+ levels stimulate eCB production, which then cross the synapse in a retrograde fashion to bind to their cannabinoid type 1 receptors (CB1r). (4) CB1r activation leads to inhibition of presynaptic CRF and glutamate release, attenuating CRF-induced increases in LC-NE excitability and NE efflux in the mPFC. (b) Male CB1r/CB2r-KO mice have increased CRF expression within the LC, which could be responsible for the heightened LC-NE excitability and subsequent NE efflux in the mPFC. (b') Female CB1r/CB2r-KO mice do not have a significant increase in CRF levels, which corresponds with the lack of change in LC-NE excitability and NE efflux in the mPFC of CB1r-KO mice compared to wild type mice. However, there is a significant increase in α2-adrenoceptor (α2-AR) expression in female CB1r/CB2r-KO mice compared to WT, while there is no significant change in α2-AR expression in males. (c) Bath application of ovine CRF (oCRF) causes a significant increase in male and female WT mice, but not in CB1r-KO mice. In males, this might be due to saturation of CRFr1 by the increased endogenous CRF levels. (c') In females, the lack of oCRFinduced increases in LC-NE excitability could be attributed to the significant increase in α2-AR expression. oCRF could induce local NE release and subsequent auto-inhibition, preventing oCRF-induced increases in LC-NE activity. [Colour figure can be viewed at wileyonlinelibrary.com] release of eCBs, which in turn retrogradely traverse the synapse. They then bind to presynaptic CB1r on CRF-containing amygdalar axon terminals, aiding in the suppression of subsequent CRF release and helping return LC-NE activity back to baseline. CB1r antagonists and inverse agonists have been investigated for a variety of disorders ranging from obesity to schizophrenia (Wyrofsky et al., 2015) . Rimonabant, a CB1r antagonist originally used for the treatment of obesity, was discontinued due to adverse psychological side effects (Nissen et al., 2008) . Based on the results obtained in this study, CB1r antagonism might not cause an increase in LC-NE excitability to the same degree in females that it would in males, and the effects from CB1r antagonist treatment might be less significant in females, highlighting the importance of using both genders when performing pre-clinical trials. Indeed, this would be in line with analyses performed on the adverse effects of rimonabant, which suggest that the odds ratio for developing depression after taking this CB1r antagonist was greatest in males aged 35-38 (Nissen et al., 2008; Pi-Sunyer, Aronne, Heshmati, Devin, & Rosenstock, 2006) . This study adds to the growing literature that dysregulation of the cannabinoid system can lead to the dysregulation of noradrenergic signaling, especially in males, helping to advance our understanding of how these systems could be targeted for more effective treatment of psychological disorders.
